About Grapple Lifesciences Private Limited
Data last updated:
Grapple Lifesciences Private Limited is a private limited company based in Manimajra, Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 November 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24230CH2011PTC033379. Its GSTIN is 04AAECG5579R1ZV (Chandigarh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4 Lakh. It is led by directors Satwant Singh and Ajay.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf 1025 First & Second Floor Motor Market, Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.93 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹17.83 Lakh (net margin 2%) and EBITDA of ₹52.36 Lakh (EBITDA margin 5.9%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years.
As per MCA filings, the company has open charges of ₹99 Lakh and satisfied charges of ₹24 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website grapplelifesciences.com.
Company details
Contact details
Grapple Lifesciences Private Limited's registered office is in Manimajra, Chandigarh. Its website is grapplelifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressScf 1025 First & Second Floor Motor Market, Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Grapple Lifesciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Grapple Lifesciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Grapple Lifesciences Private Limited, buy the company report.
Financials of Grapple Lifesciences Private Limited
FY 2025 filings availableGrapple Lifesciences Private Limited reported revenue of ₹8.93 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 31% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.36 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.83 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.9% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Grapple Lifesciences Private Limited, buy the company report.
Board of directors of Grapple Lifesciences Private Limited
Grapple Lifesciences has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satwant Singh Also directs: Ampira Biotechnics Private Limited, Qantas Labs Private Limited, Medlex Biotechnics Private Limited and 1 more | Director | 20 Nov 2012 | 13 Years 11 Months | Current |
| Ajay Also directs: Ampira Biotechnics Private Limited, Qantas Labs Private Limited, Medlex Biotechnics Private Limited and 1 more | Director | 28 Dec 2023 | 2 Years 10 Months | Current |
Peer comparison
Grapple Lifesciences Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Formulations, Healthcare Equipment Retail and Distribution, Lifesciences), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Consona Healthcare Technologies Private Limited | ₹8.95 Cr (FY 2024) | 505.0% | New Delhi, Delhi, India | |||
| Genix Lifescience Private Limited | ₹8.94 Cr (FY 2025) | 39.0% | New Delhi, Delhi, India | |||
| Grapple Lifesciences Private Limitedthis company | ₹8.93 Cr (FY 2025) | ₹17.83 Lakh | 2% | 31.0% | Manimajra, Chandigarh, India | |
| Kanhangad Links Private Limited | ₹8.91 Cr (FY 2025) | 9.0% | Kasaragod, Kerala, India | |||
| Hel India Private Limited | ₹8.9 Cr (FY 2025) | 73.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Grapple Lifesciences Private Limited, buy the company report.
Auditor
Grapple Lifesciences Private Limited is audited by VIKAS SANJIV & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIKAS SANJIV & ASSOCIATES | FY 2023 | 018361N |
Shareholding
The shareholding of Grapple Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Grapple Lifesciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Apr 2023 | 100716388 | Others | ₹99 Lakh | Open | |
| 11 Dec 2017 | 100145577 | Idbi Bank Limited | ₹10 Lakh | Satisfied | |
| 19 Nov 2015 | 10626417 | Icici Bank Limited | ₹7 Lakh | Satisfied | |
| 19 Nov 2015 | 10626419 | Icici Bank Limited | ₹7 Lakh | Satisfied |
To see the full charge records of Grapple Lifesciences Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Grapple Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Grapple Lifesciences Private Limited was last rated by Crisil on 05 Oct 2017.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 05 Oct 2017 |
To see the full credit ratings and regulatory alerts of Grapple Lifesciences Private Limited, buy the company report.
MSME payment delays
Grapple Lifesciences Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 78 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
To see the full MSME payment records of Grapple Lifesciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Grapple Lifesciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAECG5579R1ZV | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Grapple Lifesciences Private Limited, buy the company report.
Recent activity
Grapple Lifesciences Private Limited has 8 board changes on record since 2011: 2 appointments and 6 cessations. The latest: Ajay was appointed as Director on 28 Dec 2023.
6 earlier events are in the company report.
Frequently asked questions
Grapple Lifesciences is an active private limited company based in Manimajra, Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 November 2011 (15+ years old) and is registered under CIN U24230CH2011PTC033379.
Grapple Lifesciences has 2 current directors:
- Satwant Singh - Director
- Ajay - Director
The latest financial statements of Grapple Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Grapple Lifesciences is 04AAECG5579R1ZV, registered in Chandigarh.
The CIN (Corporate Identification Number) of Grapple Lifesciences is U24230CH2011PTC033379. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Grapple Lifesciences was incorporated on 21 November 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Grapple Lifesciences by revenue are Consona Healthcare Technologies Private Limited, Genix Lifescience Private Limited, Kanhangad Links Private Limited, Hel India Private Limited, all in the Healthcare industry (Formulations, Healthcare Equipment Retail and Distribution, Lifesciences), with the same principal business activity (wholesale trading).
Ajay was appointed as Director on 28 Dec 2023. Ajay ceased to be Additional Director on 30 Sep 2015. Kamaljit Singh ceased to be Director on 12 Jan 2015. Grapple Lifesciences has 8 board changes on record in total.
Grapple Lifesciences has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 78 overdue payments to 7 micro and small suppliers. The latest return was filed on 28 May 2019.
Grapple Lifesciences can be reached through the website grapplelifesciences.com. Its registered office is in Manimajra, Chandigarh, India.
The registered office of Grapple Lifesciences is at Scf 1025 First & Second Floor Motor Market, Manimajra, Chandigarh, India – 160101.
Grapple Lifesciences operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
